Observation on the effect of methylprednisolone combined with interferon in the treatment of patients with relapse remitting multiple sclerosis

VernacularTitle:甲泼尼龙联合干扰素治疗复发缓解型多发性硬化症疗效观察
Author: Xiang WU ; Jun YANG
Publication Type:Journal Article
Keywords: Multiple sclerosis,relapsing-remitting; Methylprednisolone dragon; Interferon-beta
From: Chinese Journal of Primary Medicine and Pharmacy 2012;19(3):367-369
CountryChina
Language:Chinese
Abstract: Objective To explore the effect of methylprednisolone combined with interferon in the treatment patients with relapse remitting multiple sclerosis.Methods 90 patients with relapse remitting multiple sclerosis were randomly divided into experimental group and treatment group.The experimental group during the acute stage with methylprednisolone pulse therapy,remission with interferon β (IFN-β) treatment; the control group only in the acute phase with methylprednisolone pulse therapy.Results The total effective rate of methylprednisolone pulse therapy in the acute stage was 98.9％.Experimental group during the treatment with IFN-β1α,relapse rate was 30.2％ ;patients in the control group were followed up for two years,the recurrence rate was 53.3％.Experimental group and control group was significantly different ( P ＜ 0.05 ),the experimental group was significantly lower than the control group.Conclusion For relapsing-remitting MS,using MPPT could relieve acute symptom in the acute stage,and in remission using of IFN-β1α relapse prevention was a good choice for clinicians.